Pancreatic surgery

Current Opinion in Gastroenterology

Volumn 25, Issue 5, 2009, Pages 460-465

  Hines, Oscar J ^a   Reber, Howard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute pancreatitis; Chronic pancreatitis; Pancreatic adenocarcinoma; Pancreatic cystic neoplasm; Pancreatic neuroendocrine tumor; Pancreatic surgery

Indexed keywords

ANALGESIC AGENT; FLUOROURACIL; FOLINIC ACID;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; BILE DUCT OBSTRUCTION; BLEEDING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; INSULINOMA; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LYMPH NODE; METASTASIS; MINIMALLY INVASIVE PROCEDURE; MORTALITY; NEUROENDOCRINE TUMOR; OBESITY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CYST; PANCREAS NECROSIS; PANCREAS RESECTION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PERCUTANEOUS DRAINAGE; PORTAL VEIN; REVIEW; RISK FACTOR; SEPSIS; STEREOTACTIC BODY RADIATION THERAPY; STOMACH ANTRUM RESECTION; SUPERIOR MESENTERIC VEIN; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; HUMANS; OBESITY; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 69749084212     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32832e29d2     Document Type: Review

References (22)

1. Fleming JB, Gonzalez RJ, Petzel MQ, et al. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 2009; 144:216-221. Obesity worsens the pathologic stage at the time of resection, the risk of recurrence, and survival for patients with pancreatic adenocarcinoma.
2. Williams TK, Rosato EL, Kennedy EP, et al. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2009; 208:210-217.
3. Mayo SC, Austin DF, Sheppard BC, et al. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg 2009; 208:87-95.
4. Eppsteiner RW, Csikesz NG, McPhee JT, et al. Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg 2009; 249:635-640.
5. Kazanjian KK, Hines OJ, Duffy JP, et al. Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg 2008; 143:1166-1171. Survival following resection for pancreatic adenocarcinoma may have improved to 35% at 5 years. Limiting operative blood loss appears to be at least partially responsible for this change.
6. Kaneoka Y, Yamaguchi A, Isogai M. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery 2009; 145:417-425.
7. Hurtuk MG, Hughes C, Shoup M, Aranha GV. Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg 2009; 197:348-352.
8. Neoptolemos JP, Stocken DD, Tudur Smith C, et al. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009; 100:246-250.
9. Vanderveen KA, Chen SL, Yin D, et al. Benefit of postoperative adjuvant therapy for pancreatic cancer: a population-based analysis. Cancer 2009; 115:2420-2429.
10. Moody JS, Sawrie SM, Kozak KR, et al. Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients. J Gastroenterol 2009; 44:84-91.
11. Chang DT, Schellenberg D, Shen J, et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 2009; 115:468-472. This new approach to unresectable pancreatic adenocarcinoma appears to be safe and significantly add to the longevity of these patients.
12. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6:17-32.
13. Woo SM, Ryu JK, Lee SH, et al. Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients. Br J Surg 2009; 96:405-411.
14. Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg 2009; 249:628-634.
15. Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008; 247:571-579. One of the largest series of resected MCN.
16. Hill JS, McPhee JT, McDade TP, et al. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 2009; 115:741-751. Definitive evidence that resection of the primary PNETs improves survival even in the face of metastatic disease.
17. Isla A, Arbuckle JD, Kekis PB, et al. Laparoscopic management of insulinomas. Br J Surg 2009; 96:185-190.
18. Besselink MG, van Santvoort HC, Boermeester MA, et al., Dutch Acute Pancreatitis Study Group. Timing and impact of infections in acute pancreatitis. Br J Surg 2009; 96:267-273.
19. Rocha FG, Benoit E, Zinner MJ, et al. Impact of radiologic intervention on mortality in necrotizing pancreatitis: the role of organ failure. Arch Surg 2009; 144:261-265.
20. Escourrou J, Shehab H, Buscail L, et al. Peroral transgastric/ transduodenal necrosectomy: success in the treatment of infected pancreatic necrosis. Ann Surg 2008; 248:1074-1080.
21. Keck T, Marjanovic G, Fernandez-del Castillo C, et al. The inflammatory pancreatic head mass: significant differences in the anatomic pathology of German and American patients with chronic pancreatitis determine very different surgical strategies. Ann Surg 2009; 249:105-110.
22. Guarner L, Navalpotro B, Molero X, et al. Management of painful chronic pancreatitis with single-dose radiotherapy. Am J Gastroenterol 2009; 104:349-355.